by Denise Purdie Andrews | Nov 6, 2025 | Announcements, Drug Classes
In October 2025, toxicologist Kevin Shanks made presentations at both the National Association of Medical Examiners 2025 Conference in Louisville, Kentucky, and at the Society of Forensic Toxicologists 2025 Conference in Portland, Oregon. NAME 2025 Recap:...
by Denise Purdie Andrews | Sep 17, 2025 | Announcements
We’re pleased to inform you that our Comprehensive Panel with Analyte Assurance™, along with the referenced panels below, will be updated for all orders effective September 29, 2025. The following analytes will be added: 5F-ADB Butanoic Acid Metabolite – Confirmed via...
by Denise Purdie Andrews | Jun 3, 2025 | Announcements
We’re excited to share that our Comprehensive Panel with Analyte Assurance™, as well as the below referenced panels, have been updated in all orders effective June 2nd, 2025. The analytes that have been added are as follows: ortho-Methylfentanyl – Confirmed via...
by Denise Purdie Andrews | May 28, 2025 | Announcements
Axis is pleased to recognize the four Forensic Medicine Fellows that recently completed Axis’ toxicology rotation. The rotation is a week-long virtual program where participants reviewed many aspects of a modern forensic toxicology operation, including the...
by Denise Purdie Andrews | May 12, 2025 | Announcements, Drug Classes
At this year’s MATT meeting, Dr. Laureen Marinetti spoke to attendees about how to differentiate between ketamine used illicitly versus ketamine used medically. She also discussed the origin of medical and illicit ketamine. Ketamine was developed in 1962 for use as...
by Denise Purdie Andrews | Apr 24, 2025 | Announcements
At this year’s MATT meeting, Stuart Kurtz spoke to attendees about the prevalence of nitazene analogs and the concentrations at which Axis detects them. We have previously discussed what nitazenes are in blog posts (see links below). As a reminder, they are potent mu...
